Close Menu

The Scan

In Nature this week: MassIVE.quant resource houses mass spectrometry-based proteomic data, influence of Viking genetics on European populations, and more.

According to the Wall Street Journal, Becton Dickinson is investigating reports from nursing homes regarding false positive results from its rapid COVID-19 test.

Slower Replicating

Technology Review reports synthetic biologists are developing an attenuated SARS-CoV-2 to use in a vaccine.

Extra Work

The Associated Press reports on challenges faced by Black scientists during fieldwork.

In Genome Biology this week: improved reference genome for the Asian tiger mosquito Aedes albopictus, links between Ebola variants and outcomes, and more.

Formally Sent

Reuters reports that a number of researchers have sent a letter to The Lancet critiquing its recent Russian COVID-19 vaccine paper.

Data to Look Over

According to the Los Angeles Times, National Institutes of Health officials are concerned about the possible side effect reported by a COVID-19 vaccine trial.

The New York Times reports the New York Genome Center has awarded six grants to researchers to study cancer in diverse populations.

In PNAS this week: modeling of Rift Valley Fever spillover, Asian mosquito could pose malaria threat, and more.

'Playing It Down'

The editor-in-chief of Science criticizes President Donald Trump for downplaying the COVID-19 pandemic risk.

Review Sought

Politico reports that political appointees are interfering with what appears in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Reports.

Back Up in the UK

After a pause, AstraZeneca has resumed its COVID-19 vaccine clinical trial in the UK, according to NPR.

In PLOS this week: functional effect of adiponectin-linked variants, sequencing reveals regional differences among Swedes, and more.

Oodles of Poodle

A genetic analysis of Australian labradoodles finds they are mostly poodles, the Guardian reports.

Court documents suggest Theranos' Elizabeth Holmes' defense team might rely on "expert evidence relating to a mental disease or defect," CNN reports.

Maryland has ordered 250,000 rapid coronavirus tests, according to the Washington Post.

In Science this week: additional variants linked to development of primary lymphedema, and more.

On Pause

The Washington Post reports AstraZeneca's pausing of its candidate vaccine trial indicates the science is being followed.

Researchers have uncovered more than 175 open-access journals that have disappeared from the internet, Science reports.

Top of the List

CNBC reports NIH Director Francis Collins told a congressional committee that assessing the safety and efficacy of COVID-19 vaccine is the agency's "top priority." 

In Nature this week: analysis of the effect of plasma proteins on disease phenotypes, and more.

WBUR reports Massachusetts has suspended COVID-19 testing at Orig3n following the discovery of "significant certification deficiencies."

John Kingman is to leave as chair of UK Research and Innovation in May, according to the Financial Times.

Watch the Packages

Buzzfeed News reports the University of Washington has warned researchers there to be on the lookout for suspicious packages.

In Cell this week: systems biology analysis of inflammatory syndrome seen in children with COVID-19, single-cell RNA-sequencing strategies, and more.


Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.